Who Paid My Doc
Michelle Chaussee
Physician Assistant, Medical Vermillion, SD Physician Assistant
NPI 1922247980 CMS profile 10648029
101 S Plum St, Vermillion, SD 57069
General payments
$104
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Michelle Chaussee of Vermillion, SD is reported in the CMS Open Payments database as having received $104 across 6 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 25th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $19 | 1 | |
| 2024 | General | $29 | 2 | |
| 2023 | General | $22 | 1 | |
| 2022 | General | $18 | 1 | |
| 2021 | General | $15 | 1 |
Beside peers
- Michelle Chaussee
- Physician Assistant, Medical median
- Middle half of Physician Assistant, Medical
- National median
In program year 2025, general payments to Michelle Chaussee were reported at $19. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.
Show as a table
| Year | Michelle Chaussee | Physician Assistant, Medical median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $61 | $19–$193 | $163 |
| 2020 | $0 | $20 | $14–$64 | $114 |
| 2021 | $15 | $156 | $41–$563 | $132 |
| 2022 | $18 | $185 | $55–$649 | $149 |
| 2023 | $22 | $199 | $58–$717 | $160 |
| 2024 | $29 | $206 | $62–$740 | $164 |
| 2025 | $19 | $214 | $62–$755 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 128 drugsPart D claims
5,642
Drug cost
$415,457
Branded share of claims
23.9%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | Brand | 69 | $60,730 | |
| Trulicity Dulaglutide | Brand | 43 | $44,484 | |
| Ozempic Semaglutide | Brand | 41 | $39,490 | |
| Eliquis Apixaban | Brand | 57 | $37,216 | |
| Farxiga Dapagliflozin Propanediol | Brand | 26 | $29,297 | |
| Xarelto Rivaroxaban | Brand | 30 | $20,132 | |
| Mounjaro Tirzepatide | Brand | 18 | $18,855 | |
| Januvia Sitagliptin Phosphate | Brand | 15 | $14,627 | |
| Linzess Linaclotide | Brand | 17 | $14,408 | |
| Breo Ellipta Fluticasone/Vilanterol | Brand | 34 | $13,606 |
The 10 drugs with the highest cost, of 128 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 135 billing codesPaid by Medicare
$122,559
Medicare patients
288
Services billed
5,367
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 72% | |
| Arthritis | 33% | |
| Diabetes | 29% | |
| Ischemic heart disease | 22% | |
| Chronic kidney disease | 16% | |
| Atrial fibrillation | 14% | |
| Heart failure | 11% | |
| Depression | 11% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Vaccine for influenza for injection into muscle 90662 | Office | 44 | 44 | $3,580 |
| Pcv20 vaccine im 90677 | Office | 11 | 11 | $3,185 |
| Sarscv2 vac 30mcg trs-suc im 91320 | Office | 16 | 16 | $2,444 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
6 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Physician Assistant, Medical in South Dakota
Molly Schooley
Physician Assistant, Medical · Dakota Dunes, SD
Crystal Oberle
Physician Assistant, Medical · Dakota Dunes, SD
David Feist
Physician Assistant, Medical · Watertown, SD
Sarah Engbers
Physician Assistant, Medical · Sioux Falls, SD
Ashley Anziano
Physician Assistant, Medical · Rapid City, SD
Sarah Brend
Physician Assistant, Medical · Dakota Dunes, SD
Related records
Physician Assistant, Medical in South Dakota
Practitioners in the same specialty and state, ranked by reported value.
All Physician Assistant, Medical
Everyone recorded under this specialty, nationwide.
Doctors in South Dakota
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.